Aster Medcity bags Center of Excellence in Antimicrobial Stewardship Designation by IDSA

The programme recognises institutions that have implemented a robust Antimicrobial Stewardship Program over years using the multi-pronged interventions

Aster Medcity has been conferred by the Infectious Diseases Society of America (IDSA) with the Center of Excellence title in Antimicrobial Stewardship. The programme recognises institutions that have implemented a robust Antimicrobial Stewardship Program over years using the multi-pronged interventions recommended by the Centers for Disease Control and Prevention (CDC) and can demonstrate results that meet global standards. 

The Antimicrobial Stewardship Program (AMSP) highlights the structural and process measures for AMSP comprehensively implemented by an organisation/hospital and continuously monitors its outcomes, with interventions focused on improving them. The aim is to ensure that patients with infectious complications/syndromes managed by the hospital are provided with appropriate antimicrobial therapy that is evidence-based and to achieve the best results, curtailing the collateral damage of evolving antimicrobial resistance.

Dr Anup R Warrier, Head – Infectious Diseases and Infection Control, Aster DM Healthcare – India Units, said, “ To improve patient outcomes and reduce resistance, we are committed to AMS by practising an integrated approach to AMS, combining clinical infectious diseases, infection control, microbiology, and clinical pharmacy inputs – all implemented using the unique ‘Handshake Model’.